Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trial-论文-万方医学网

Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trial

导出原文传递

翻译打印收藏纠错

作者： Crothers, Jessica W. ^[1] ; Colgate, Elizabeth Ross ^[2] ; Cowan, Kelly J. ^[3] ; Dickson, Dorothy M. ; Walsh, MaryClaire ; Carmolli, Marya ; Wright, Peter F. ; Norton, Elizabeth B. ; Kirkpatrick, Beth D.

作者单位： Univ Vermont ^[1] Geisel Sch Med Dartmouth ^[2] Tulane Univ ^[3]

关键词 Polio Vaccine Injectable Adjuvant Mucosal Immunity INTESTINAL IMMUNITY OPEN-LABEL ANTIBODY-RESPONSES MUCOSAL IMMUNITY INFANTS IMMUNOGENICITY IMMUNIZATION WORLDWIDE OUTBREAKS DELIVERY

发布时间 2022-07-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trial

相似文献

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Intradermal fractional-dose inactivated polio vaccine (fIPV) adjuvanted with double mutant Enterotoxigenic Escherichia coli heat labile toxin (dmLT) is well-tolerated and augments a systemic immune response to all three poliovirus serotypes in a randomized placebo-controlled trial

相似文献

相关期刊

检索历史清除